Genworth Financial Inc Common Stock vs Intuitive Surgical, Inc. — how do they compare? Genworth Financial Inc Common Stock trades at $8.82 (market cap $3.33B), while Intuitive Surgical, Inc. trades at $422.44 (market cap $148.46B). The key difference: Intuitive Surgical, Inc. is far larger — about 44.6× Genworth Financial Inc Common Stock's market cap, and Genworth Financial Inc Common Stock is more actively traded (3,324,561 versus 1,914,576). Which is the better fit depends on your goals — on Pluang, investors hold Genworth Financial Inc Common Stock for 0 Days and Intuitive Surgical, Inc. for 84 Days on average.
| GNW | ISRG | |
|---|---|---|
Market Cap | $3.33B | $148.46B |
Volume | 3,324,561 | 1,914,576 |
Sector | Financials | Health |
52-Week High | $10.60 | $592.85 |
52-Week Low | $7.94 | $332.02 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $2.85B | $143.25B |
Signals from Pluang's Aura AI — not financial advice
Genworth Financial (GNW) trades at $8.89, down 1.77% today, with neutral technical signals and mixed fundamental performance. The company maintains stable revenue around $7.1-7.2B but faces margin pressure, with net income declining from $223M to $212M year-over-year. Recent Q2 2026 earnings beat expectations at $0.29 EPS, while the company expanded its share repurchase program by $500M in September 2026.
GNW presents value characteristics with low P/B (0.38) and P/S (0.49) ratios, but weak profitability metrics (ROE 2.42%) and analyst caution (70.59% hold rating) suggest limited near-term catalysts. Key risks include legacy insurance liabilities and competitive pressures, while the upcoming Q3 earnings on November 4 could provide directional clarity.
Intuitive Surgical (ISRG) trades at $422.06, down 1.3% on the day, but maintains strong fundamentals with consistent earnings beats and robust revenue growth from $6.2B in 2022 to $10.1B in 2025. The stock shows bullish technical signals with support at $414 and resistance at $431, while analyst consensus remains strongly positive with a $480.78 price target. Recent expansion into India and Japan helps offset China weakness, with da Vinci 5 upgrades driving recurring revenue streams.
ISRG presents a compelling growth opportunity with market leadership in robotic surgery and expanding international presence, though elevated valuation multiples (P/E 48.4) and competitive pressures warrant caution. The 70% buy rating from analysts suggests significant upside potential, but investors should monitor procedure growth rates and macroeconomic pressures affecting healthcare spending.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Genworth Financial, Inc. is a holding company that provides products and services related to aging and long-term care planning, and is the parent company of publicly traded mortgage insurer Enact Holdings, Inc.
Read more on GNW →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →